Trial Profile
A Pilot Open-Label Single-Dose Study Using Intravenous Micellar Paclitaxel for Patients With Severe Psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 May 2014
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 22 May 2014 New trial record